Cargando…
Inhibition of LPA(5) Activity Provides Long-Term Neuroprotection in Mice with Brain Ischemic Stroke
Stroke is a leading cause of long-term disability in ischemic survivors who are suffering from motor, cognitive, and memory impairment. Previously, we have reported suppressing LPA(5) activity with its specific antagonist can attenuate acute brain injuries after ischemic stroke. However, it is uncle...
Autores principales: | Sapkota, Arjun, Park, Sung Jean, Choi, Ji Woong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585638/ https://www.ncbi.nlm.nih.gov/pubmed/33024060 http://dx.doi.org/10.4062/biomolther.2020.159 |
Ejemplares similares
-
BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
por: Gaire, Bhakta Prasad, et al.
Publicado: (2020) -
Receptor for Advanced Glycation End Products Is Involved in LPA(5)-Mediated Brain Damage after a Transient Ischemic Stroke
por: Sapkota, Arjun, et al.
Publicado: (2021) -
Oleanolic Acid Provides Neuroprotection against Ischemic Stroke through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation
por: Sapkota, Arjun, et al.
Publicado: (2022) -
NLRP3 Inflammasome Activation Is Involved in LPA(1)-Mediated Brain Injury after Transient Focal Cerebral Ischemia
por: Lee, Chi-Ho, et al.
Publicado: (2020) -
Lysophosphatidic acid receptor 1 (LPA(1)) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia
por: Gaire, Bhakta Prasad, et al.
Publicado: (2019)